EN | UA
EN | UA

Help Support

Back

Execution of an IV Dihydroergotamine Protocol for Refractory Migraine in pediatric patients

Execution of an IV Dihydroergotamine Protocol for Refractory Migraine in pediatric patients Execution of an IV Dihydroergotamine Protocol for Refractory Migraine in pediatric patients
Execution of an IV Dihydroergotamine Protocol for Refractory Migraine in pediatric patients Execution of an IV Dihydroergotamine Protocol for Refractory Migraine in pediatric patients

A retrospective study was aimed to find the efficiency of IV DHE therapy for refractory migraine in the pediatric patients.

See All

Key take away

From a recent study, it was found that dihydroergotamine (DHE) treatment for refractory migraine in children is effective. As per the findings, data support repetitive IV DHE as an unsuccessful therapy for children suffering from status migrainosus or chronic migraine. 

Background

A retrospective study was aimed to find the efficiency of IV DHE therapy for refractory migraine in the pediatric patients.

Method

A chart analysis to evaluate the efficiency of IV DHE therapy protocol in the cases of refractory migraine in the pediatric population was done. According to cohort, depending on a chart review consisting of 159 patients (mean age 15 ± 2 years) who were given IV DHE for nine years at the University of Virginia Children’s Hospital were identified. The median total dose of DHE was about 4.0 mg. Overall, 38% (60/159) patients who completed the course of DHE received 8 or 9 total doses. Patients were classified as having completed the DHE protocol or not.

Result

At discharge, 60% (96/159) of patients got free from headache, but no statistically important variation was seen in headache among status migrainosus, chronic migraine and other headache categories. There was no variation in pain relief results at the record in the dihydroergotamine protocol complete and incomplete groups.

Table: Headache diagnosis 

Conclusion

The intravenous administration of dihydroergotamine for refractory migraine in children was found beneficial.

Source:

Headache

Article:

Implementation of an Intravenous Dihydroergotamine Protocol for Refractory Migraine in Children

Authors:

Liana M Theroux et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ua ru
Try: